Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biopharmadive.com/news/neumora-clinical-hold-schizophrenia-drug-fda/713182/
https://www.globenewswire.com/news-release/2024/04/15/2862602/0/en/Neumora-Therapeutics-Announces-Clinical-Hold-of-Phase-1-NMRA-266-Study.html
https://www.globenewswire.com//news-release/2024/03/13/2845280/0/en/Neumora-Therapeutics-to-Participate-at-Stifel-2024-Virtual-CNS-Days.html
https://www.globenewswire.com//news-release/2024/03/07/2842102/0/en/Neumora-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/01/22/2812887/0/en/Neumora-Therapeutics-Appoints-Kaya-Pai-Panandiker-as-Chief-Commercial-Officer.html
https://www.globenewswire.com//news-release/2024/01/02/2802562/0/en/Neumora-Therapeutics-to-Present-at-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/12/12/2794605/0/en/Neumora-Therapeutics-Appoints-Jason-Duncan-as-Chief-Legal-Officer.html
https://www.globenewswire.com//news-release/2023/11/27/2786021/0/en/Neumora-Therapeutics-Announces-NMRA-266-IND-Clearance-and-Initiation-of-Phase-1-Clinical-Study.html
https://www.globenewswire.com//news-release/2023/11/01/2770987/0/en/Neumora-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2023/10/30/2769021/0/en/Neumora-Therapeutics-to-Participate-in-Upcoming-Conferences-in-November.html